ARCHIVES

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

This article is from The Cancer Letter archive.

Vol. 32 No. 01 | January 13, 2006

Download PDF Visit The Full Archive

Related Articles

Surveillance Colonoscopy Cost-Effective For High-Risk

July 30, 2010

Marvin Schneiderman To Retire March 1

February 8, 1980

House Aims to End Budget Markup Early; Natcher Sees Most Difficult Year

June 26, 1992

Low Percentage Of Trials Published In Medical Journals

October 31, 2008

U.S. Cancer Mortality Dropped Slightly In 2003, ACS Report Finds.

February 10, 2006

Knudson To Head Fox Chase Center

November 21, 1980